Active, not recruitingObservationalUpdated Apr 24, 2026
Survey on the Pharmacy Follow-up of Alli Purchasers | NCT01387243 | Trialant
CompletedObservationalUpdated Oct 29, 2012
Survey on the Pharmacy Follow-up of Alli Purchasers
Survey on the Pharmacy Follow up of Alli Purchasers
ClinicalTrials.gov ID
NCT01387243
Lead Sponsor
GlaxoSmithKlineINDUSTRY
Overall Status
Completed
Study Type
Observational
Enrollment
80Actual
Last Update Posted
Oct 29, 2012Estimated
Start Date
Jan 2010
Primary Completion Date
Dec 2010Actual
Completion Date
Dec 2010Actual
Official Title
Survey on the Pharmacy Follow up of Alli Purchasers
Brief Summary
To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.
Overweight
Orlistat
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.